Catalyst Pharmaceuticals, Inc.
Records under this name other than the patents Catalyst Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 3 of 3 · Back to Catalyst Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,772,497 | Method for producing 1, 2-dihydropyridine-2-one compound Term ended Term ended May 16, 2026 · From the USPTO record | Term ended | Term ended May 16, 2026 | From the USPTO record |
| US 9,045,426 | Method for Producing 1,2-Dihydropyridine-2-ONE Compound Term ended Term ended Jul 5, 2025 · Medium confidence | Term ended | Term ended Jul 5, 2025 | Medium confidence |
| US 6,949,571 | 1,2-Dihydropyridine Compounds, Process for Preparation of the Same and Use Thereof Term ended Term ended May 23, 2025 · High confidence | Term ended | Term ended May 23, 2025 | High confidence |